Obi Umeh, MD, MSc, VP, Franchise Global Program Leader at Takeda, discusses interim results from a study investigating mezagitamab for the treatment of patients with IgA nephropathy. This…
Dana Rizk, MD, professor of medicine at the University of Alabama at Birmingham, discusses the approval of Fabhalta (iptacopan) for adults with IgA nephropathy. Iptacopan, a Factor B…
Chronic kidney disease often goes unnoticed until it reaches an advanced stage. Early detection can help treat and prevent the disease before it necessitates dialysis or kidney transplantation.…
Sheeram Akilesh, MD, PhD, discusses spatial transcriptomics and its application in studying kidney disease. He explains the concept of spatial transcriptomics, which involves deeply interrogating a tissue section…
Nephrologist Sumeska Thavarajah, MD, of Johns Hopkins, discusses the management of chronic kidney disease. She explains that medications are prescribed to treat risk factors that can speed up…
Terry J. Watnick, MD, professor of neurology and director of Maryland PKD Clinical Center of Excellence, explains that polycystic kidney disease (PKD) is a genetic disorder that causes…
Dinushika Mohottige, MD, a general nephrologist and assistant professor at the ICAHN School of Medicine at Mount Sinai, discusses the causes, symptoms, and treatments of kidney disease. The…
Nephrologist Sumeska Thavarajah, MD, of Johns Hopkins, discusses treatment options for end-stage kidney disease, also known as end-stage renal disease. The treatments include dialysis, transplantation, or medical management,…
Brian Shuch, MD, director of the UCLA Kidney Cancer Program, explains what to expect after a radical nephrectomy. The procedure can be done minimally invasively, either laparoscopically or robotically,…
Heather N. Reich, MD, CM, PhD, FRCPC, Oreopoulos-Baxter Division Director of Nephrology, University of Toronto, discusses translating new clinical trials in IgA nephropathy, a kidney disease. Dr Reich…
April W. Armstrong, MD, MPH, of @KeckMedUSC, and Erin E. Boh, MD, PhD, of @TulaneMedicine, discuss the use of IL-23 and IL-17 inhibitors in #psoriaticdisease.
